Hydrocodone Bitartrate + Acetaminophen Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: hydrocodone / acetaminophen: 5 mg/325 mg, 7.5 / 325 mg, 10 mg / 325 mg
Reference Brands: Vicodin, Norco, Lortab(US)
Category:
Analgesic
Hydrocodone + Acetaminophen combine activate opioid receptors, reducing pain signals and perception. Acetaminophen enhances analgesia and fever reduction. Benefits include effective relief from moderate to severe pain, improved comfort, and rapid onset. It’s frequently prescribed post-surgery or injury, but requires careful use due to dependence and overdose risks.
Hydrocodone bitartrate + Acetaminophen tablets is available in Tablets
and strengths such as hydrocodone / acetaminophen: 5 mg/325 mg, 7.5 / 325 mg, 10 mg / 325 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hydrocodone bitartrate + Acetaminophen tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydrocodone bitartrate + Acetaminophen tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hydrocodone + Acetaminophen tablets are approved in the US for moderate to severe pain, regulated by the DEA and FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the EU, such combination products are regulated by EMA, requiring comprehensive dossiers and pharmacovigilance plans. Due to high addiction potential, strict controls, prescribing regulations, and monitoring are enforced in both regions. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access, ensuring adherence to European and US standards for safe, effective use of opioid combination therapy while navigating complex regulatory pathways seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing